In 1982, recombinant human insulin became the first biotech therapy to earn FDA approval. The product was developed by Genentech and Eli Lilly and Co.
- For Students
- For Teachers
- Programs
- International BioGENEius Challenge
- Testimonials
- Volunteer Opportunities
- U.S. National BioGENEius Challenge
- Local BioGENEius Challenges
- At-Large BioGENEius Challenge Competition
- Your World Magazine
- About the Institute
- Supporters
- What is Biotechnology?
